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In this age of the genome-wide association study, our 
ability to identify genomic regions associated with 
disease has made great advances; however, our ability to 
translate this into a better understanding of the mecha-
nisms of disease and genetic susceptibility is still limited. 
In the previous issue of Breast Cancer Research [1], the 
continued study of the Mcs5a locus, which was ﬁ  rst 
identiﬁ   ed in 2001 in 7,12-dimethylbenz(a)anthracene 
(DMBA)-treated rats and validated as relevant in humans 
in 2007 [2,3], has stretched our perspectives by high-
lighting how the functional role of a breast cancer suscep-
tibility allele may be outside of the mammary epithelial 
cell, the target cell of breast carcinogenesis, and may 
originate outside of the mammary gland itself. Th  e  study 
utilizes congenic rat lines developed on a susceptible 
(Wistar-Furth) genetic background, and carrying the 
selected resistant (Wistar-Kyoto) Mcs5a alleles, up to 
approxi  mately 116 kb in size [3]. By performing trans-
plantation experiments, Smits and colleagues [1] clearly 
demonstrate that the mammary carcinoma susceptibility 
phenotype mediated by Mcs5a is not transferable by 
transplantation of the mammary gland [1]. As their 
previous work had indicated expression of genes (Fbxo10
and Frmpd1) within the Mcs5a locus diﬀ  ered in immune 
tissues but not in mammary glands of resistant compared 
to susceptible rats [3], the involvement of the immune 
system was investigated with a bone marrow transplan-
tation approach. While there are technical limitations to 
these experiments, the number of carcinomas in resistant 
hosts bearing marrow from susceptible donors was 60% 
higher than in resistant hosts bearing marrow from 
resistant donors, indicating that Mcs5a can act through 
components of the immune system to modulate 
mammary carcinoma susceptibility. Investigation of the 
immune cells of the resistant rats found an association 
with an overabundance of γδ T-cell receptor (TCR)+ T 
cells (important in mucosal surface surveillance), higher 
L-selectin expression (which may promote extravasation), 
increased mitogen-induced proliferation and increased 
production of Th  1 (but not Th  2) cytokines compared 
with susceptible rats [1].
While the target cell for Mcs5a originates outside the 
mammary gland, the phenotype is most strongly ex-
pressed within the carcinogen-exposed mammary gland. 
Th  e T-cell diﬀ   erences were markedly greater in the 
T cells isolated from mammary ductal fragments or from 
the inguinal lymph nodes of rats treated with DMBA. 
Further, γδ-TCR+ T cells of the mammary gland 
displayed diﬀ  erent cell surface markers to the splenic γδ-
TCR+ T cells, and while γδ-TCR+ T cells are the 
predominant T-cell type in the mammary gland, they are 
a very minor population in the carcinomas arising in 
these rats [1]. Th   is highlights the importance of analyzing 
the function of candidate genes in the appropriate tissue 
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typic diﬀ   erences of modiﬁ   er alleles may be subtle or 
highly speciﬁ   c and therefore easily overlooked in the 
wrong setting. Such functional studies, especially involv-
ing the preneoplastic/susceptible normal gland, are much 
more readily achieved in rodent models than with human 
tissue [4].
Not only has the Mcs5a locus challenged the dominant 
paradigm that genetic susceptibility to mammary 
carcinomas will be due to phenotypes expressed in the 
mammary gland, it has also pushed our understanding of 
how the phenotypic diﬀ   erences are played out at the 
DNA level. In a second paper, Smits and colleagues [5] 
begin to elucidate the molecular mechanisms of the 
genetic variants. Th  e Mcs5a locus consists of two non-
protein coding genetic elements that must be on the 
same chromosome to elicit the phenotype [3]. Smits and 
colleagues [5] identify a conserved looping structure in 
the DNA, where the looped elements are bound by CTCF 
and cohesion. Th  is brings the polymorphic Mcs5a/
MCS5A 1 and 2 elements, which are separated by over 60 
kb in the genome, physically close together to mediate 
their transcriptional regulatory diﬀ  erences,  controlling 
the expression of Fbxo10 in T cells [5].
Th  e  deﬁ  nitive experiments are still to be done to prove 
that Fbxo10 expression in T cells is the pathway mediat-
ing the resistant phenotype of the Mcs5a locus. Th  ese 
could include examining the eﬀ   ect of tissue-speciﬁ  c 
disruption of Fxbo10 in T cells on tumour development, 
or examination of tumour susceptibility in the congenic 
rat lines after depletion of T cells. Nonetheless, the 
current reports from the Gould laboratory are consistent 
with Mcs5a mediating its phenotype through an immune 
surveillance mechanism within the mammary gland. 
Over the past 10 years, evidence has been accumulating 
that cells of the immune system are required for the 
prevention of cancer [6], such that ‘evading immune 
destruction’ has been included as an emerging hallmark 
of cancer in a recent revision of the landmark paper from 
Hanahan and Weinberg [7].
Th  e relevance of the Mcs5a locus to human breast 
cancer is clear, as MCS5A2 has recently been shown to be 
among the most signiﬁ   cant of a list of 710 candidate 
breast cancer risk alleles, modifying risk to both hormone 
receptor-positive and -negative breast cancer [8]. With 
odds ratios of 1.19 and 0.77 and minor allele frequencies 
of 0.26 and 0.12 for MCS5A1 and MCS5A2, respectively, 
they are classiﬁ   ed as high population frequency, low 
penetrance modiﬁ   er alleles [3]. Smits and colleagues 
provide further evidence supporting the broad relevance 
of this locus to breast cancer by showing that the resistant 
congenic rats are also resistant to mammary carcinomas 
induced by an alternative carcinogen (N-nitroso-N-
methylurea, or NMU) or HER2/neu overexpression. 
Interestingly, resistance to HER2/neu in situ carcinomas 
was not evident, indicating that Mcs5a is not acting 
during tumour initiation, but is acting during early 
mammary cancer progression [1], an observation consis-
tent with Mcs5a mediating its phenotype through an 
immune surveillance mechanism.
Here we have the ﬁ   rst evidence that this low 
penetrance, high frequency genetically determined breast 
cancer risk factor may be acting through the immune 
system, aﬀ  ecting long-range gene expression via novel 
gene regulatory elements involving three-dimensional 
looping DNA structures. Th   e understanding of the three-
dimensional structure of DNA and chromatin and how it 
can impact on disease susceptibility takes the idea of 
functional testing of single nucleotide polymorphisms to 
a whole extra level of complexity. Adding to this that the 
target tissue of the polymorphism may not be the 
mammary gland, but could be the immune system, or 
other extra-mammary systems, functional investigations 
become expensive and complex. With our rodent helpers, 
we will continue to gnaw our way through these barriers 
to understanding the phenotypic expression of genetic 
variants involved in complex diseases, to fulﬁ  l  the 
promises of novel pathways and therapeutic or preventive 
approaches oﬀ   ered by the age of the genome-wide 
association study.
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